Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide english literature and 13 cases at Kyoto University

Liver Transplantation

Volumn 11, Issue 11, 2005, Pages 1332-1342

  Morioka, Daisuke ^a,b   Kasahara, Mureo ^a   Takada, Yasutsugu ^c   Shirouzu, Yasumasa ^a   Taira, Kaoru ^a   Sakamoto, Seisuke ^a   Uryuhara, Kenji ^a   Egawa, Hiroto ^a   Shimada, Hiroshi ^b   Tanaka, Koichi ^c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATOCYTE TRANSPLANTATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; HYPERAMMONEMIA; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SAFETY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; UREA CYCLE DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; PATIENT SELECTION; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TISSUE DONORS; UREA;

EID: 30444448372     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20587     Document Type: Review

References (42)

1. Bachmann C. Inherited hyperammonemia. In: Blau et al., eds. Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases. 2nd ed. Berlin: Springer, 2003:261-276.
2. Online Mendelian Inheritance in Man. #311250, Ornithine transcarbamylase deficiency; #237300, Carbamoyl phosphate synthetase deficiency; #207800, Argininemia; #207900, Argininosuccinicaciduria; #215700, Citrullinemia, classic; #603471, Citrullinemia, Type II, Adult-onset; CTLN2; #237310, N-acetyl glutamate synthetase deficiency. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM
3. Leonard JV, McKiernan PJ. The role of liver transplantation in urea cycle disorders. Molecul Genet Metabol 2004;81:S74-S78.
4. Whitington PF, Alonso EM, Boyle JT, Molleston JP, Rosenthal P, Emond JC, Millis JM. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998;21(Suppl 1):S112-S118.
5. Largilliere C, Houssin D, Gottrand F, Mathey C, Checoury A, Alagille D, et al. Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr 1989:115:415-417.
6. Tuchman M. Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency. N Engl J Med 1989;320:1498-1499.
7. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990;212:368-375.
8. Todo S, Starzle TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992;15:419-422.
9. Jan D, Poggi F, Jouvet P, Rabier D, Laurent J, Beringer A, et al. Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. Transplant Proc 1994; 26:188.
10. Hasegawa T, Tzaksi AG, Todo S, Reyes J, Nour B, Finegold DN, et al. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995;30:863-865.
11. Kawamoto S, Strong RW, Kerlin P, Lynch SV, Steadman K, Nakagawa S, et al. Orthotopic liver transplantation for adult-onset type II citrullinemia. Clin Transpl 1997;11:453-458.
12. Busuttil AA, Goss JA, Seu P, Dulkanchainun TS, Yanni GS, McDiarmid SV, Busuttil RW. The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency. Liver Transpl Surg 1998;4:350-354.
13. Fletcher JM, Couper R, Moore D, Coxon R, Dorney S. Liver transplantation for citrullinemia improves intellectual function. J Inherit Metab Dis 1999;22:581-586.
14. Takenaka K, Yasuda I, Araki H, Fukutomi Y, Ohnishi H, Yamakita N, et al. Type II citrullinemia in an elderly patient treated with living related partial liver transplantation. Intern Med 2000;39:553-558.
15. Kasahara M, Ohwada S, Takeichi T, Kaneko H, Tomomasa T, Morikawa A, et al. Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. Transplantation 2001;71:157-159.
16. Ban K, Sugiyama N, Sugiyama K, Wada Y, Suzuki T, Hashimoto T, et al. A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation. Transplantation 2001;71:1495-1497.
17. Santos Silva E, Martins E, Cardoso ML, Barber C, Vilarinho L, Medina M. Liver transplantation in a case of argininaemia. J Inherit Metab Dis 2001;24:885-887.
18. Ikeda S, Yazaki M, Takei Y, Ikegami T, Hashikura Y, Kawasaki S, et al. Type II (adult onset) citrullinemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 2001;71:663-670.
19. Tamamori A, Okano Y, Ozaki H, Fujimoto A, Kajiwara M, Fukuda K, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 2002;161:609-613.
20. Yazaki M, Hashikura Y, Takei Y, Ikegami T, Miyagawa S, Yamamoto K, et al. Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia. Liver Transpl 2004;10:550-554.
21. McBride KL, Miller G, Carter S, Karpen S, Goss J, Lee B. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset ornithine transcarbamylase deficiency. Pediatrics 2004;114:523-526.
22. Uemoto S, Yabe S, Inomata Y, Nishizawa H, Asonuma K, Tanaka K, et al. Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation 1997;63:1026-1028.
23. Kasahara M, Kiuchi T, Uryuhara K, Ogura Y, Takakura K, Tanaka K, et al. Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program. J Pediatr Surg 1998;33: 1753-1756.
24. Kasahara M, Takada Y, Kozaki K, Uryuhara K, Ogura Y, Tanaka K, et al. Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease. J Pediatr Surg 2004; 39:1138-1141.
25. Hauser ER, Finkelstein JE, Valle D, Brusilow SW. Allopurinol-induced orotiduria. A test for mutations at the ornithine carbamoyltransferase locus in women. N Engl J Med 1990;322: 1641-1645.
26. Arranz JA, Riudor E, Rodes M, Roig M, Climent C, Rubio V, et al. Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency. Clin Chem 1999;45:995-1001.
27. Morimoto T, Ichiyama M, Tanaka A, Ikai I, Yamamoto Y, Nakamura Y, et al. Guidelines for donor selection and an overview of the donor operation in living related liver transplantation. Transpl Int 1996;9:208-213.
28. Fujita S, Kim ID, Uryuhara K, Asonuma K, Egawa H, Kiuchi T, et al. Hepatic grafts from live donors: donor morbidities for 470 cases of liver donation. Transpl Int 2000;13:333-339.
29. Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein. Nat Genet 1999;22:159-163.
30. Keeffe EB. Selection of patients for liver transplantation. In: Maddrey WC, et al., eds. Transplantation of the Liver. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2001:5-34.
31. Belanger-Quintana A, Martinez-Pardo M, Garcia MJ, Wermuth B, Torres J, Pallares E, Ugarte M. Hyperammonaemia as a cause of psychosis in an adolescent. Eur J Pediatr 2003;162:773-775.
32. Kasahara M, Kaihara S, Oike F, Ito T, Fujimoto Y, Tanaka K, et al. Living-donor liver transplantation with monosegments. Transplantation 2003;76:694-696.
33. Sugawara Y, Makuuchi M. Advances in adult living donor liver transplantation: a review based on reports from the 10th anniversary of the adult-to-adult living donor liver transplantation meeting in Tokyo. Liver Transpl 2004;10:715-720.
34. Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Tanaka K, et al. Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl 2003;9(Suppl 9): S29-S35.
35. Ito T, Kiuchi T, Egawa H, Kaihara S, Oike F, Tanaka K, et al. Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 2003;76: 158-163.
36. Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation 2004;77:634.
37. Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ. Gene therapy as an alternative to liver transplantation. Liver Transpl 2002;8:1089-1108.
38. Ohashi K, Park F, Kay MA. Hepatocyte, transplantation: clinical and experimental application. J Mol Med 2001;79:617-630.
39. Kasahara M, Takada Y, Egawa H, Fujimoto Y, Ogura Y, Ogawa K, et al. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant 2005;5: 558-565.
40. Plochl W, Spiss CK, Plochl E. Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency. N Engl J Med 1999;341:921-922.
41. Yorifuji T, Muroi J, Uematsu A, Tanaka K, Kiwaki K, Endo F, et al. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin Genet 1998; 54:349-353.
42. McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates under the PELD system. Liver Transpl 2004;10(Suppl 2):S23-S30.